Evaluation of Guideline Recommendations for Dual Antipseudomonal Therapy in Hospitalized Adults with Pneumonia Using Combination Antibiograms

ConclusionsRisk factors necessitating dual antipseudomonal therapy for pneumonia should be locally validated. When dual antipseudomonal therapy is indicated, tobramycin or amikacin have the best likelihood of providing adequate in vitro activity.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - November 3, 2020 Category: Drugs & Pharmacology Authors: Quyen Luu, Kaylee Vitale, Guogen Shan, Rebecca Jayakumar, Velliyur Viswesh Tags: Original Research Article Source Type: research